Airway inflammation in COPD: progress to precision medicine

@article{Brightling2019AirwayII,
  title={Airway inflammation in COPD: progress to precision medicine},
  author={Christopher E. Brightling and Neil J. Greening},
  journal={European Respiratory Journal},
  year={2019},
  volume={54}
}
Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity and mortality worldwide, and its prevalence is increasing. Airway inflammation is a consistent feature of COPD and is implicated in the pathogenesis and progression of COPD, but anti-inflammatory therapy is not first-line treatment. The inflammation has many guises and phenotyping this heterogeneity has revealed different patterns. Neutrophil-associated COPD with activation of the inflammasome, T1 and T17 immunity… 
Airway Inflammation Biomarker for Precise Management of Neutrophil-Predominant COPD.
TLDR
Understanding the details of increased neutrophils and dysbacteriosis in COPD is necessary for making precise management strategy against neutrophil-associated COPD.
Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease
TLDR
The current challenges and unmet needs in the management of acute exacerbations of COPD, including triggers, biological clusters, current treatment strategies, and their limitations, previously studied biomarkers and prediction tools, the lung microbiome and its role in COPD exacerbations as well as future directions are discussed.
Alteration of immune profiles is associated with pulmonary function and symptoms in patients with chronic obstructive pulmonary disease
  • Sixiang Li, Shuang Zhao, Zhenru Wu, Fangfang Wang, Weimin Li
  • Medicine
    Molecular medicine reports
  • 2021
TLDR
Significant differences in profiles of immune factors among patients with COPD, smokers and non-smoking controls and their association with clinical characteristics are revealed.
Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke.
TLDR
The basic pathogenesis of COPD is discussed, with particular focus on an endogenous protective mechanism against oxidative stress via Nrf2, altered immune response of the airway inflammatory cells, exaggerated cellular senescence of the lung structural cells, and cell death with expanded inflammation.
IFLAMMATION, HYPOXIA, AND ANEMIA IN PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: LITERATURE REVIEW AND OWN RESEARCH
TLDR
Inflammation, hypoxia and anaemia are three connected links of pathogenesis of COPD, which create vicious circle and possibly determine disease progression.
An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
TLDR
With a more in-depth understanding of the numerous pheno/endotypic pathways that play a role in COPD, it may eventually be possible to identify those specific patients in whom some of these cytokines or chemokines might predominate and implement a personalized treatment.
The Role of Epithelial Damage in the Pulmonary Immune Response
TLDR
The role of epithelial-derived damage-associated molecular patterns (DAMPs) and senescence in shaping the immune response and their contribution to inflammatory and fibrotic signalling pathways in the lung are highlighted.
Mendelian randomisation analyses of eosinophils and other blood cell types in relation to lung function and disease.
TLDR
Evidence is found that eosinophils reduce lung function, and increase ACO and asthma risk, on average over the set of genetic variants studied, which may arise from pleiotropy.
Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD
TLDR
High BNC may provide a useful indicator of risk of exacerbations and mortality in COPD patients and in a sub-cohort, patients with elevated BNC had increased relative abundance of Proteobacteria and reduced microbiome diversity.
Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium
TLDR
Recent novel findings that elucidate how respiratory viral infections alter the epithelial barrier in the airways, the upper airway microbial environment, epigenetic modifications including miRNA modulation, and other changes in immune responses throughout the upper and lower airways are focused on.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 85 REFERENCES
Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease
TLDR
The mechanisms of eosinophilic trafficking, the tools to assess eosInophilic airway inflammation in asthma and COPD during stable disease and exacerbations are discussed and current and novel anti-eos inophilic treatments are reviewed.
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
TLDR
Observations suggest that eosinophilic airway inflammation in COPD is a predictive biomarker of corticosteroid responsiveness during clinical stability and exacerbations.
Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease.
TLDR
The association of the T2S score with increased severity and "asthma-like" features (including a favorable corticosteroid response) in COPD suggests that Th2 inflammation is important in a COPD subset that cannot be identified by clinical history of asthma.
An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup
TLDR
Data suggest that a gene signature of IL-17 airway epithelial response distinguishes a biologically, radiographically, and clinically distinct COPD subgroup that may benefit from personalized therapy.
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis
TLDR
The improvement in forced expiratory volume in 1 s (FEV1) is also associated with a decrease in biomarkers of airway remodelling, such as sputum hyaluronan and versican, over a 6-month treatment period, which is not known if the same benefits are observed in patients with COPD and eosinophilia.
Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease.
TLDR
The observed relationship between AT and lung function supports a role for autoimmunity in the pathogenesis of COPD.
Blood eosinophil thresholds and exacerbations in chronic obstructive pulmonary disease
TLDR
Patients with moderate-to-severe COPD and blood eosinophil counts of 300 cells/μL or greater had an increased risk exacerbations in the COPDGene study, which was prospectively validated in the ECLIPSE study.
Asthma
TLDR
A clinically focused overview of asthma, including epidemiology, pathophysiology, clinical diagnosis, asthma phenotypes, severe asthma, acute exacerbations, and clinical management of disease in adults and children older than 5 years is provided.
COPD immunopathology
TLDR
The immunopathology of COPD patients, of different severity, compared with control smokers with normal lung function, is summarized and discussed.
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.
TLDR
Subjects with moderate to severe COPD did not benefit from treatment with infliximab and the impact of inflIXimab on malignancy risk in patients with COPD needs to be further elucidated.
...
1
2
3
4
5
...